Literature DB >> 8813862

Bone marrow transplant for sickle cell disease--an update.

S C Davies1, I A Roberts.   

Abstract

Mesh：

Year:  1996        PMID： 8813862      PMCID： PMC1511667          DOI： 10.1136/adc.75.1.3

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  23 in total

1.  Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency.

Authors:  D B Kohn; K I Weinberg; J A Nolta; L N Heiss; C Lenarsky; G M Crooks; M E Hanley; G Annett; J S Brooks; A el-Khoureiy
Journal:  Nat Med       Date:  1995-10       Impact factor: 53.440

2.  Hydroxyurea and sickle cell crisis.

Authors:  R T Silver
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

3.  Hydroxyurea and sickle cell crisis.

Authors:  P T Ho; A J Murgo
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

4.  Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity.

Authors:  A Ferster; F Corazza; F Vertongen; W Bujan; C Devalck; P Fondu; P Cochaux; M Lambermont; Z Khaladji; E Sariban
Journal:  Br J Haematol       Date:  1995-08       Impact factor: 6.998

5.  Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease.

Authors:  J E Wagner; N A Kernan; M Steinbuch; H E Broxmeyer; E Gluckman
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

6.  Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.

Authors:  G D Sher; G D Ginder; J Little; S Yang; G J Dover; N F Olivieri
Journal:  N Engl J Med       Date:  1995-06-15       Impact factor: 91.245

7.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

8.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; M L Terrin; R D Moore; G J Dover; F B Barton; S V Eckert; R P McMahon; D R Bonds
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

9.  Availability of related donors for bone marrow transplantation in sickle cell anemia.

Authors:  W C Mentzer; S Heller; P R Pearle; E Hackney; E Vichinsky
Journal:  Am J Pediatr Hematol Oncol       Date:  1994-02

10.  Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect.

Authors:  T C Kloosterman; A C Martens; D W van Bekkum; A Hagenbeek
Journal:  Bone Marrow Transplant       Date:  1995-04       Impact factor: 5.483
View more
  2 in total

Review 1.  Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa).

Authors:  Ademola Samson Adewoyin
Journal:  Anemia       Date:  2015-01-18

2.  Factors associated with continuing emergence of β-thalassemia major despite prenatal testing: a cross-sectional survey.

Authors:  Haleama Al Sabbah; Sarah Khan; Abdallah Hamadna; Lamia Abu Ghazaleh; Anwar Dudin; Bashar Adnan Karmi
Journal:  Int J Womens Health       Date:  2017-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.